MA
60
3
BF.B
51
-2
MSI
43
2
MHK
42
-6
MLM
54
3
PPL
80
5
BEN
34
4
MTCH
48
4
KSS
23
2
OXY
45
5
CVX
58
3
EXPE
66
5
ZBH
65
3
HPE
19
3
LRCX
55
6
MCO
64
8
AMP
66
3
ESS
59
5
NWS
66
4
GOOG
55
2
MA
60
3
BF.B
51
-2
MSI
43
2
MHK
42
-6
MLM
54
3
PPL
80
5
BEN
34
4
MTCH
48
4
KSS
23
2
OXY
45
5
CVX
58
3
EXPE
66
5
ZBH
65
3
HPE
19
3
LRCX
55
6
MCO
64
8
AMP
66
3
ESS
59
5
NWS
66
4
GOOG
55
2
Financhill
Back

NeuroPace Stock Predictions

Economy going through a "period of transition" - Your portfolio doesn't have to

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32

NPCE
NeuroPace

Last Price:
$11.28
Seasonality Move:
-26.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

NeuroPace Stock Forecast

  • Over the next 52 weeks, NeuroPace has on average historically risen by 58.4% based on the past 3 years of stock performance.
  • NeuroPace has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is NeuroPace Stock Undervalued?
    The current NeuroPace [NPCE] share price is $10.74. The Score for NPCE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • NPCE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will NeuroPace Stock Go Up Next Year?

  • Over the next 52 weeks, NeuroPace has on average historically risen by 58.4% based on the past 3 years of stock performance.

NeuroPace Stock Rating

Sell
32
NeuroPace (NPCE) is a Sell

Is NeuroPace overpriced?

  • NeuroPace has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

NeuroPace Stock Price History

Is NPCE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NPCE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
neuropace.com

52-Week Data

52-Week High:
15.77
52-Week Low:
5.45

Prediction Charts

Market Cap:
349.6M
Price in USD:
10.74
Volume:
97.8K
Beta:
2.07

Technical Analysis

SMA50:
12.57
SMA100:
10.80
SMA200:
8.95
52-Wk Change:
-21.23%

Stock Predictions

  • Is NeuroPace stock public?
    Yes, NeuroPace is a publicly traded company.
  • What is the NeuroPace stock quote today?
    The NeuroPace stock price is 10.74 USD today.
  • How to buy NeuroPace stock online?
    You can buy NeuroPace shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-21 14.20 13.75 14.21 13.25
Feb-25 13.41 13.85 13.97 13.32
Feb-26 13.61 13.48 13.97 13.26
Feb-27 13.53 12.52 13.64 12.32
Feb-28 12.51 12.94 13.10 12.30
Mar-3 12.85 11.80 12.87 11.71
Mar-4 11.62 11.92 12.22 11.10
Mar-5 12.65 11.64 12.97 10.52
Mar-6 11.47 11.18 11.63 10.55
Mar-7 11.09 10.97 11.21 10.53
Mar-11 10.06 10.36 10.42 9.56
Mar-12 10.35 10.97 11.09 10.24
Mar-13 10.95 10.43 11.01 10.19
Mar-14 10.69 10.74 10.82 10.49

NeuroPace Earnings

NeuroPace Earnings Report: Per Share NeuroPace Earnings Q1 Q2 Q3 and Q4 last year and next year.

NeuroPace Forecast Revenue Growth

NeuroPace Stock Analysis: Historical quarterly revenues per share for NeuroPace and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.05 per share, an increase this year of $0.14 per share, and an increase next year of $0.15 per share.

* NeuroPace stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.